Thienopyrimidine derivatives as potassium channel inhibitors

Details for Australian Patent Application No. 2004247470 (hide)

Owner Xention Discovery Limited

Inventors Palmer, Nicholas John; Madge, David John; Sherborne, Brad; Bushfield, Mark; Atherall, John Frederick; Ford, John; Stevens, Edward Benedict

Agent FB Rice

Pub. Number AU-B-2004247470

PCT Pub. Number WO2004/111057

Priority 0315950.6 11.06.03 GB; 60/477,518 11.06.03 US

Filing date 10 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 23 April 2009

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/111057 Priority application(s): WO2004/111057

23 April 2009 Application Accepted

  Published as AU-B-2004247470

9 July 2009 Alteration of Name

  The name of the applicant has been altered to Xention Limited

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247480-Fertilizer compositions

2004247469-2-hydroxymethyl-3,4,5-trihydroxy-1-ben zilpiperidine derivatives as inhibitors of glucosylceramide